Wade's Healthcare Privacy Advisor for October 2, 2024


July 22, 2026

Superintelligence in a Decade?

OpenAI CEO Sam Altman has outlined his vision of accelerated human advancement through AI, predicting the emergence of superintelligent AI within the next decade. Altman touts the transformative potential of AI, likening it to past technological revolutions, and credits deep learning as the catalyst for this new era.

He foresees AI assistants becoming integral to various fields, significantly enhancing productivity and innovation. While acknowledging potential labor market disruptions, Altman remains optimistic about AI’s overall societal impact. He calls for substantial infrastructure investment to democratize AI access and warns of the risks associated with limited resources.

Despite criticism, Altman urges a balanced approach, advocating for wise yet decisive actions to navigate the challenges of this transformative period. Ultimately, he envisions a future of unprecedented prosperity driven by AI advancements.

In the Field

Cybersecurity

Data Privacy

Generative AI

Legislation

Opinion

Wade Emmert

Partner & Healthcare Practice Group Leader

Board Certified, Health Law // Certified Information Privacy Professional (CIPP/US) // Artificial Intelligence Governance Professional (AIGP) // Certified in Cybersecurity (ISC2 CC)

Healthcare Empowered Podcast

Thanks for reading! If you loved it, tell your friends to subscribe. To change your email or preferences manage your profile. You can unsubscribe here.

901 Main Street, Suite 5500, Dallas, TX 75202

Wade Emmert

Carrington, Coleman, Sloman & Blumenthal, LLP

Read more from Wade Emmert

July 22, 2026 This week Laboratory Corporation of America agreed to pay $14.5 million to settle False Claims Act allegations that it billed Medicare for unnecessary urine drug tests by routinely running and charging for both presumptive and definitive testing on the same sample under its “ToxAssure Comprehensive” panel. iMessage can’t be made HIPAA compliant no matter how you configure it, because Apple won’t sign a Business Associate Agreement, backs up messages to iCloud with keys stored on...

July 22, 2026 This week The Texas Supreme Court ruled that omissions claims under the Texas Health Care Program Fraud Prevention Act must prove materiality even though the statute never uses that word, holding that a defendant who disclosed its conduct and kept getting paid without objection had effectively negated any claim that the omitted pricing information mattered to the government’s payment decision. Express Scripts is suing Texas Attorney General Ken Paxton to block the full release...

July 22, 2026 This week HHS Secretary Robert F. Kennedy Jr. has stacked the FDA’s Pharmacy Compounding Advisory Committee with nine new members largely favorable to peptide use, just ahead of July meetings on whether compounding pharmacies can produce unproven peptides like BPC-157 that FDA scientists say lack sufficient evidence of safety and efficacy. OIG Advisory Opinion No. 26-15 concludes that a home health agency’s payment of per-hospital subscription fees for online referral management...